These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 15514374

  • 1. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
    Marks LB, Garst J, Socinski MA, Sibley G, Blackstock AW, Herndon JE, Zhou S, Shafman T, Tisch A, Clough R, Yu X, Turrisi A, Anscher M, Crawford J, Rosenman J, Carolina Conformal Therapy Consortium.
    J Clin Oncol; 2004 Nov 01; 22(21):4329-40. PubMed ID: 15514374
    [Abstract] [Full Text] [Related]

  • 2. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ, Movsas B, Hudes R, Schol J, Keenan E, Kilpatrick D, Yeung C, Curran W.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [Abstract] [Full Text] [Related]

  • 3. Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trial.
    Socinski MA, Rosenman JG, Schell MJ, Halle J, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC.
    Cancer; 2000 Aug 01; 89(3):534-42. PubMed ID: 10931452
    [Abstract] [Full Text] [Related]

  • 4. Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.
    Socinski MA, Clark JA, Halle J, Steagall A, Kaluzny B, Rosenman JG.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-117-S12-122. PubMed ID: 9331135
    [Abstract] [Full Text] [Related]

  • 5. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH, Ahn SJ, Pyo HR, Kim KS, Kim YC, Moon SH, Han JY, Kim HT, Koom WS, Lee JS.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1397-404. PubMed ID: 19117690
    [Abstract] [Full Text] [Related]

  • 6. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 01; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 7. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP, Wang W, Johnson DH, Wagner H, Schiller J, Veeder M, Mehta M, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3760-7. PubMed ID: 15837967
    [Abstract] [Full Text] [Related]

  • 8. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.
    Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1106-12. PubMed ID: 15519781
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of combined radiation, paclitaxel and carboplatin for locally advanced non-small cell lung carcinoma.
    Nguyen NP, Leonardo JM, Karlsson U, Vos P, Bullock L, Thomas P, Lepera P, Ludin A, Chu C, Salehpour M, Jendrasiak G, Sallah S.
    Anticancer Res; 2002 Nov 15; 22(6B):3429-35. PubMed ID: 12552935
    [Abstract] [Full Text] [Related]

  • 10. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 15; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 11. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
    Jeremić B, Milicić B, Acimović L, Milisavljević S.
    J Clin Oncol; 2005 Oct 01; 23(28):6873-80. PubMed ID: 16192579
    [Abstract] [Full Text] [Related]

  • 12. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
    Rojas AM, Lyn BE, Wilson EM, Williams FJ, Shah N, Dickson J, Saunders MI.
    Cancer; 2006 Sep 15; 107(6):1321-30. PubMed ID: 16902985
    [Abstract] [Full Text] [Related]

  • 13. Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer.
    Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K, Johnson DH.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-21-S12-26. PubMed ID: 9331115
    [Abstract] [Full Text] [Related]

  • 14. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A.
    Lung Cancer; 2007 Nov 15; 58(2):238-45. PubMed ID: 17658655
    [Abstract] [Full Text] [Related]

  • 15. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: long-term results of a phase II study.
    Jeremic B, Milicic B, Acimovic L, Milisavljevic S.
    J Clin Oncol; 2005 Feb 20; 23(6):1144-51. PubMed ID: 15718310
    [Abstract] [Full Text] [Related]

  • 16. Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial.
    Pöttgen C, Eberhardt WE, Gauler T, Krbek T, Berkovic K, Jawad JA, Korfee S, Teschler H, Stamatis G, Stuschke M.
    Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):809-15. PubMed ID: 19427744
    [Abstract] [Full Text] [Related]

  • 17. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan 01; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 18. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
    Schild SE, McGinnis WL, Graham D, Hillman S, Fitch TR, Northfelt D, Garces YI, Shahidi H, Tschetter LK, Schaefer PL, Adjei A, Jett J.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1106-11. PubMed ID: 16730134
    [Abstract] [Full Text] [Related]

  • 19. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):318-28. PubMed ID: 15667949
    [Abstract] [Full Text] [Related]

  • 20. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.
    Edelman MJ, Suntharalingam M, Burrows W, Kwong KF, Mitra N, Gamliel Z, Riley M, Cooper LB, Kennedy NL, Buskirk S, Hausner P, Doyle LA, Krasna MJ.
    Ann Thorac Surg; 2008 Sep 01; 86(3):903-10. PubMed ID: 18721580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.